
July 25 (Reuters) - Moderna Inc MRNA.O:
MODERNA: EMA'S CHMP ADOPTS POSITIVE OPINION RECOMMENDING AUTHORIZATION OF MODERNA'S COVID-19 MRNA VACCINE TARGETING THE SARS-COV-2 VARIANT LP.8.1
MODERNA: UPDATED COVID-19 MRNA VACCINE WILL BE AVAILABLE FOR 2025-2026 VACCINATION SEASON, PENDING EUROPEAN COMMISSION AUTHORIZATION DECISION